QuickLogic Corporation , a leading provider of embedded FPGA (eFPGA) Hard IP, and ruggedized FPGAs, today announced the integration of the Synopsys Synplify® synthesis tool into its FPGA User Tools.

MZ will work closely with Quantum BioPharma management to develop and implement a comprehensive capital markets strategy designed to increase the Company’s visibility throughout the investment ...

Biopharmaceutical company Quantum BioPharma (QNTM) has seen its stock rocket up roughly 230% in the past month. The company ...

Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd. ("Intas Pharmaceuticals"), focused on the ...

Quantum BioPharma TORONTO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a ...

Quantum BioPharma Ltd. has announced the retention of Enterprise Canada Inc. and Empire Market Ventures, LLC to enhance its public relations and investor awareness programs in key markets.

Can-Fite BioPharma Ltd. has announced an upcoming investor webinar scheduled for February 25, 2025, at 4:15 p.m. ET, hosted by RedChip Companies. The session will feature insights from Can-Fite's ...

TORONTO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) ("Quantum BioPharma” or the "Company”), a biopharmaceutical company dedicated ...

Accord BioPharma Inc., the U.S. specialty division of Intas Pharmaceuticals Ltd., has reached an exclusive commercialization and license agreement with Bio-Thera Solutions for BAT2506, a biosimilar ...

The company has debuted its newest venture—GondolaBio, a biopharma startup. It will focus on developing therapies for genetic and rare diseases. Overall BBIO ranks 12th on our list of the best ...